SC 13G | 2024-02-02 | INTRACOASTAL CAPITAL, LLC | RedHill Biopharma Ltd. | 1,250,000 | 4.0% | EDGAR |
SC 13G | 2024-02-01 | CVI Investments, Inc. | RedHill Biopharma Ltd. | 700,000,000 | 5.9% | EDGAR |
SC 13G/A | 2024-01-08 | Empery Asset Management, LP | RedHill Biopharma Ltd. | 647,824 | 3.2% | EDGAR |
SC 13G/A | 2024-01-02 | SABBY MANAGEMENT, LLC | RedHill Biopharma Ltd. | 0 | 0.0% | EDGAR |
SC 13G | 2023-01-13 | Empery Asset Management, LP | RedHill Biopharma Ltd. | 5,906,124 | 6.1% | EDGAR |
SC 13G | 2023-01-04 | SABBY MANAGEMENT, LLC | RedHill Biopharma Ltd. | 7,540,400 | 8.4% | EDGAR |
SC 13G | 2022-03-07 | Cosmo Pharmaceuticals N.V. | RedHill Biopharma Ltd. | 69,000,010 | 13.2% | EDGAR |
SC 13G/A | 2022-01-27 | Ibex Investors LLC | RedHill Biopharma Ltd. | 1,310,940 | 0.3% | EDGAR |
SC 13G/A | 2021-01-15 | Ibex Investors LLC | RedHill Biopharma Ltd. | 22,777,100 | 5.5% | EDGAR |
SC 13G/A | 2020-02-13 | 683 Capital Management, LLC | RedHill Biopharma Ltd. | 1,034,650 | 3.6% | EDGAR |
SC 13G/A | 2020-01-27 | Ibex Investors LLC | RedHill Biopharma Ltd. | 17,700,000 | 5.0% | EDGAR |
SC 13G | 2019-06-17 | Ibex Investors LLC | RedHill Biopharma Ltd. | 14,522,040 | 5.1% | EDGAR |
SC 13G/A | 2019-02-19 | First Investments Holding Ltd | RedHill Biopharma Ltd. | 3,928,571 | 13.8% | EDGAR |
SC 13G | 2019-02-19 | First Investments Holding Ltd | RedHill Biopharma Ltd. | 3,928,571 | 18.4% | EDGAR |
SC 13G/A | 2019-02-14 | 683 Capital Management, LLC | RedHill Biopharma Ltd. | 3,693,840 | 13.0% | EDGAR |
SC 13G | 2018-08-06 | 683 Capital Management, LLC | RedHill Biopharma Ltd. | 2,797,686 | 13.1% | EDGAR |
SC 13G | 2018-01-16 | 683 Capital Management, LLC | RedHill Biopharma Ltd. | 1,409,037 | 6.6% | EDGAR |
SC 13G/A | 2017-02-13 | OrbiMed Israel BioFund GP Limited Partnership | RedHill Biopharma Ltd. | 817,532 | 4.9% | EDGAR |
SC 13G/A | 2017-02-10 | Broadfin Capital, LLC | RedHill Biopharma Ltd. | 356,773 | 2.2% | EDGAR |
SC 13G | 2017-01-06 | EMC2 Fund Ltd. | RedHill Biopharma Ltd. | 2,195,123 | 11.9% | EDGAR |